Sofosbuvir Plus an NS5A Inhibitor for HCV GT3 and Cirrhosis Sofosbuvir Plus an NS5A Inhibitor for HCV GT3 and Cirrhosis

This study evaluated the efficacy of regimens of SOF plus an NS5A inhibitor with or without RBV in this group.Journal of Viral Hepatitis
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news